Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Cardiac Muscle Equipment Supplied In Europe
4 equipment items found
Manufactured by:Ncardia Services B.V. based inLeiden, NETHERLANDS
Disturbances in calcium signaling are associated with many neurodegenerative diseases and cardiomyopathies. Fluorescence-based assays with iPSC-derived cardiac and neuronal models can be used to monitor short and long-term drug-induced changes on calcium transients. Our scientists develop the most optimal calcium transient assay for each project and can scale it up for high-throughput screening, ...
Manufactured by:Biopanda Reagents Ltd based inBelfast, UNITED KINGDOM
This Point-of-Care rapid test, is a rapid chromatographic immunoassay, for the qualitative detection of human H-FABP in whole blood (venipuncture or fingerstick blood), serum, or plasma samples. Results are available in 10 minutes, to assist health professionals in diagnosing Acute Myocardial Infarction ...
by:Corscience GmbH & Co. KG based inErlangen, GERMANY
Defibrillators can save lives. Whether you’re up against life-threatening arrhythmias or atrial fibrillation, whether it be bradycardia or conduction disorders – with the right current pulses, it’s possible to bring the heart back into the right rhythm. In this regard, the task of modern defibrillation technology is to cause as little tissue damage as possible through the ...
Manufactured by:CellProthera based inMulhouse, FRANCE
The unique therapeutic approach proposed by CellProthera is protected by various patents. It requires a simple blood sampling best performed within 2 weeks following a severe AMI. The sampling occurs after a treatment period using GCSF in order to mobilize the patient’s own stem cells into the blood flow. The patient’s blood sample is then forwarded to a local certified Cell Therapy ...